| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |